UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 71

Sortiert nach

Comparison of survival distributions in clinical trials: A practical guidance

Clinical trials (London, England), 2020-10, Vol.17 (5), p.507-521

2020

Link zum Volltext

Verfügbarkeit prüfen

A framework for assessing the impact of accelerated approval

PloS one, 2022-06, Vol.17 (6), p.e0265712-e0265712

2022

Link zum Volltext

Verfügbarkeit prüfen

Clinicopathologic Analysis of Invasive Micropapillary Differentiation in Breast Carcinoma

Modern pathology, 2001-09, Vol.14 (9), p.836-841

2001

Link zum Volltext

Verfügbarkeit prüfen

Assessing Contribution of Treatment Phases through Tipping Point Analyses via Counterfactual Elicitation Using Rank Preserving Structural Failure Time Models

Statistics in biopharmaceutical research, 2023-07, Vol.15 (3), p.661-674

2023

Link zum Volltext

Verfügbarkeit prüfen

Pathologic analysis of tumor size and lymph node status in multifocal/multicentric breast carcinoma

Cancer, 2002-03, Vol.94 (5), p.1383-1390

2002

Link zum Volltext

Verfügbarkeit prüfen

Stabilization of ultra-small gold nanoparticles in a photochromic organic cage: modulating photocatalytic CO2 reduction by tuning light irradiation

Journal of materials chemistry. A, Materials for energy and sustainability, 2021-01, Vol.9 (9), p.5780-5786

2021

Link zum Volltext

Verfügbarkeit prüfen

Angular power spectrum of supernova remnants: effects of structure, geometry, and diffuse foreground

Monthly notices of the Royal Astronomical Society, 2021-03, Vol.501 (3), p.3364-3370

2021

Link zum Volltext

Verfügbarkeit prüfen

Sterically controlled isodesmic late-stage C-H iodination of arenes

Chemical science (Cambridge), 2023-04, Vol.14 (16), p.4357-4362

2023

Link zum Volltext

Verfügbarkeit prüfen

Gas Dynamics in the Star-forming Region G18.148–0.283: Is It a Manifestation of Two Colliding Molecular Clouds?

The Astrophysical journal, 2022-01, Vol.925 (1), p.60

2022

Link zum Volltext

Verfügbarkeit prüfen

Palladium(II)-Catalyzed Nondirected Late-Stage C(sp2)-H Deuteration of Heteroarenes Enabled Through a Multi-Substrate Screening Approach

Angewandte Chemie International Edition, 2024-03, p.e202404421-e202404421

2024

Link zum Volltext

Verfügbarkeit prüfen

INTELLANCE 2/EORTC 1410 randomized phase II study of Depatux-M alone and with temozolomide vs temozolomide or lomustine in recurrent EGFR amplified glioblastoma

Neuro-oncology (Charlottesville, Va.), 2020-05, Vol.22 (5), p.684-693

2020

Link zum Volltext

Verfügbarkeit prüfen

Stabilization of ultra-small gold nanoparticles in a photochromic organic cage: modulating photocatalytic CO reduction by tuning light irradiation

Journal of materials chemistry. A, Materials for energy and sustainability, 2021-03, Vol.9 (9), p.578-5786

2021

Link zum Volltext

Verfügbarkeit prüfen

Stabilization of ultra-small gold nanoparticles in a photochromic organic cage: modulating photocatalytic CO 2 reduction by tuning light irradiation

Journal of materials chemistry. A, Materials for energy and sustainability, 2021-03, Vol.9 (9), p.5780-5786

2021

Link zum Volltext

Verfügbarkeit prüfen

Power Analysis of Collapsed Ordered Categories with Application to Cancer Data

Bulletin - Calcutta Statistical Association, 2018-11, Vol.70 (2), p.87-95

2018

Link zum Volltext

Verfügbarkeit prüfen

Well‐defined Bis(imino)pyridine‐Manganese(II) Complexes for Oxidation of Benzylic C−H Bonds

Zeitschrift für anorganische und allgemeine Chemie (1950), 2024-04, Vol.650 (7), p.n/a

2024

Link zum Volltext

Verfügbarkeit prüfen

Statistical Issues and Recommendations for Clinical Trials Conducted During the COVID-19 Pandemic

Statistics in biopharmaceutical research, 2020-10, Vol.12 (4), p.399-411

2020

Link zum Volltext

Verfügbarkeit prüfen

Zinc‐bis(imino)pyridine Complexes as Catalysts for Azide‐Alkyne Cycloaddition in Water

ChemistrySelect (Weinheim), 2022-12, Vol.7 (48), p.n/a

2022

Link zum Volltext

Verfügbarkeit prüfen

Rationale and protocol of the Study Of diabetic Nephropathy with AtRasentan (SONAR) trial: A clinical trial design novel to diabetic nephropathy

Diabetes, obesity & metabolism, 2018-06, Vol.20 (6), p.1369-1376

2018

Link zum Volltext

Verfügbarkeit prüfen

Updated Safety and Efficacy of REGN5458, a BCMAxCD3 Bispecific Antibody, Treatment for Relapsed/Refractory Multiple Myeloma: A Phase 1/2 First-in-Human Study

Blood, 2022-11, Vol.140 (Supplement 1), p.10140-10141

2022

Link zum Volltext

Verfügbarkeit prüfen

Phase I study of the anti-CD40 humanized monoclonal antibody lucatumumab (HCD122) in relapsed chronic lymphocytic leukemia

Leukemia & lymphoma, 2012-11, Vol.53 (11), p.2136-2142

2012

Link zum Volltext

Verfügbarkeit prüfen

Estimands for overall survival in clinical trials with treatment switching in oncology

Pharmaceutical statistics : the journal of the pharmaceutical industry, 2022-01, Vol.21 (1), p.150-162

2022

Link zum Volltext

Verfügbarkeit prüfen

Corrigendum to INTELLANCE 2/EORTC 1410 randomized phase II study of Depatux-M alone and with temozolomide vs temozolomide or lomustine in recurrent EGFR amplified glioblastoma

Neuro-oncology (Charlottesville, Va.), 2021-08, Vol.23 (8), p.1415-1415

2021

Link zum Volltext

Verfügbarkeit prüfen

8pter–p23 Deletion Is Associated with Racial Differences in Prostate Cancer Outcome

Clinical cancer research, 2000-12, Vol.6 (12), p.4647-4652

2000

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 71

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(59)
Mit Volltextzugriff
(62)

Publikationsform

Sprache

Englisch
(70)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Comparison of survival distributions in clinical trials: A practical guidance

A framework for assessing the impact of accelerated approval

Clinicopathologic Analysis of Invasive Micropapillary Differentiation in Breast Carcinoma

Assessing Contribution of Treatment Phases through Tipping Point Analyses via Counterfactual Elicitation Using Rank Preserving Structural Failure Time Models

Pathologic analysis of tumor size and lymph node status in multifocal/multicentric breast carcinoma

Stabilization of ultra-small gold nanoparticles in a photochromic organic cage: modulating photocatalytic CO2 reduction by tuning light irradiation

Angular power spectrum of supernova remnants: effects of structure, geometry, and diffuse foreground

Sterically controlled isodesmic late-stage C-H iodination of arenes

Gas Dynamics in the Star-forming Region G18.148–0.283: Is It a Manifestation of Two Colliding Molecular Clouds?

Palladium(II)-Catalyzed Nondirected Late-Stage C(sp2)-H Deuteration of Heteroarenes Enabled Through a Multi-Substrate Screening Approach

INTELLANCE 2/EORTC 1410 randomized phase II study of Depatux-M alone and with temozolomide vs temozolomide or lomustine in recurrent EGFR amplified glioblastoma

Stabilization of ultra-small gold nanoparticles in a photochromic organic cage: modulating photocatalytic CO reduction by tuning light irradiation

Stabilization of ultra-small gold nanoparticles in a photochromic organic cage: modulating photocatalytic CO 2 reduction by tuning light irradiation

Power Analysis of Collapsed Ordered Categories with Application to Cancer Data

Well‐defined Bis(imino)pyridine‐Manganese(II) Complexes for Oxidation of Benzylic C−H Bonds

Statistical Issues and Recommendations for Clinical Trials Conducted During the COVID-19 Pandemic

Zinc‐bis(imino)pyridine Complexes as Catalysts for Azide‐Alkyne Cycloaddition in Water

Rationale and protocol of the Study Of diabetic Nephropathy with AtRasentan (SONAR) trial: A clinical trial design novel to diabetic nephropathy

Updated Safety and Efficacy of REGN5458, a BCMAxCD3 Bispecific Antibody, Treatment for Relapsed/Refractory Multiple Myeloma: A Phase 1/2 First-in-Human Study

Phase I study of the anti-CD40 humanized monoclonal antibody lucatumumab (HCD122) in relapsed chronic lymphocytic leukemia

Estimands for overall survival in clinical trials with treatment switching in oncology

Corrigendum to INTELLANCE 2/EORTC 1410 randomized phase II study of Depatux-M alone and with temozolomide vs temozolomide or lomustine in recurrent EGFR amplified glioblastoma

8pter–p23 Deletion Is Associated with Racial Differences in Prostate Cancer Outcome

INTELLANCE 2/EORTC 1410 randomized phase II study of Depatux-M alone and with temozolomide vs temozolomide or lomustine in recurrent EGFRamplified glioblastoma

Updated results of the INTELLANCE 2/EORTC trial 1410 randomized phase II study on Depatux –M alone, Depatux-M in combination with temozolomide (TMZ) and either TMZ or lomustine (LOM) in recurrent EGFR amplified glioblastoma (NCT02343406)

Suchergebnisse filtern